Allergy Therapeutics (AGY) News Today GBX 6.80 +0.14 (+2.10%) As of 02/21/2025 11:46 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsHeadlines All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Allergy Therapeutics (LON:AGY) Trading Down 8.9% - Here's WhyAllergy Therapeutics (LON:AGY) Stock Price Down 8.9% - Here's WhyFebruary 18, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Up 2.2% - Here's WhyAllergy Therapeutics (LON:AGY) Shares Up 2.2% - What's Next?February 4, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Down 10.4% - Here's WhyAllergy Therapeutics (LON:AGY) Stock Price Down 10.4% - Time to Sell?February 3, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Reaches New 1-Year High - Here's What HappenedAllergy Therapeutics (LON:AGY) Reaches New 1-Year High - Time to Buy?January 21, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Hits New 1-Year High - Here's What HappenedAllergy Therapeutics (LON:AGY) Sets New 52-Week High - Still a Buy?January 13, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Hits New 52-Week High - Here's WhyAllergy Therapeutics (LON:AGY) Hits New 1-Year High - Still a Buy?January 6, 2025 | marketbeat.comAllergy Therapeutics (LON:AGY) Sets New 12-Month High - Time to Buy?Allergy Therapeutics (LON:AGY) Hits New 1-Year High - What's Next?December 31, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Passes Above 50-Day Moving Average - Here's What HappenedAllergy Therapeutics (LON:AGY) Shares Cross Above Fifty Day Moving Average - Should You Sell?December 31, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Sets New 12-Month High - Here's What HappenedAllergy Therapeutics (LON:AGY) Sets New 1-Year High - What's Next?December 23, 2024 | marketbeat.comSMALL CAP IDEA: Allergy Therapeutics transformation has redefined its trajectoryDecember 23, 2024 | msn.comAllergy Therapeutics (LON:AGY) Sets New 52-Week High - Here's WhyAllergy Therapeutics (LON:AGY) Sets New 12-Month High - Here's WhyDecember 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Passes Above Two Hundred Day Moving Average - Should You Sell?Allergy Therapeutics (LON:AGY) Shares Pass Above Two Hundred Day Moving Average - Time to Sell?December 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Shares Down 11.6% - What's Next?Allergy Therapeutics (LON:AGY) Shares Down 11.6% - Here's WhyDecember 6, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Up 6.9% - Still a Buy?Allergy Therapeutics (LON:AGY) Trading Up 6.9% - Still a Buy?December 6, 2024 | marketbeat.comThose who invested in Allergy Therapeutics (LON:AGY) a year ago are up 178%November 26, 2024 | uk.finance.yahoo.comAllergy Therapeutics Seeks Approval for Grass Allergy TreatmentNovember 26, 2024 | markets.businessinsider.comAllergy Therapeutics Unveils Incentive Plans and Share RepurchaseNovember 21, 2024 | markets.businessinsider.comAllergy Therapeutics (LON:AGY) Stock Price Passes Below 200 Day Moving Average - What's Next?Allergy Therapeutics (LON:AGY) Shares Cross Below 200 Day Moving Average - Here's What HappenedNovember 14, 2024 | marketbeat.comAllergy Therapeutics Shows Financial Turnaround and Clinical ProgressNovember 7, 2024 | markets.businessinsider.comAllergy Therapeutics Sees Growth and Strategic AdvancesNovember 7, 2024 | markets.businessinsider.comAllergy Therapeutics (LON:AGY) Shares Down 7.2% - Here's What HappenedAllergy Therapeutics (LON:AGY) Stock Price Down 7.2% - What's Next?October 17, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Trading Up 17.6% - What's Next?Allergy Therapeutics (LON:AGY) Trading Up 17.6% - Here's What HappenedOctober 16, 2024 | marketbeat.comAllergy Therapeutics (LON:AGY) Stock Price Down 17.5% - Here's What HappenedAllergy Therapeutics (LON:AGY) Trading Down 17.5% - Here's What HappenedOctober 7, 2024 | marketbeat.comECU research emphasizes proper evaluation for children with potential antibiotic allergies Research From Edith ...September 18, 2024 | msn.comAllergy Therapeutics (LON:AGY) Trading Down 9.8%Allergy Therapeutics (LON:AGY) Shares Down 9.8%September 4, 2024 | marketbeat.comAllergy Therapeutics secures cash to see it through SeptemberAugust 27, 2024 | lse.co.ukAllergy Therapeutics (LON:AGY) Shares Down 8.9% Allergy Therapeutics (LON:AGY) Stock Price Down 8.9%August 27, 2024 | marketbeat.comFood Allergy Awareness Week 2024: How can new treatments target an unmet need?May 16, 2024 | msn.comBuy Rating Justified for Aquestive Therapeutics Amidst Innovative Allergy Treatment and Strong Financial ProspectsMay 10, 2024 | markets.businessinsider.comGlobal Skin Allergy Testing Market Expected to Reach $771.5 Million by 2028May 9, 2024 | tmcnet.comSkin patch improves treatment for pediatric milk allergiesMay 2, 2024 | msn.comGlobal Skin Allergy Testing Market Report 2024: Revenue Data for 2020-2022, Estimated Figures for 2023, and Forecasts for 2028 - ResearchAndMarkets.comApril 27, 2024 | businesswire.comThe most common 'inhalant' allergiesApril 18, 2024 | dailymail.co.ukAllergy Therapeutics First Half 2024 Earnings: UK£0.006 loss per share (vs UK£0.013 loss in 1H 2023)March 29, 2024 | finance.yahoo.comAIM WINNERS & LOSERS: Norman Broadbent profit swing on rising revenueMarch 28, 2024 | lse.co.ukAllergy Therapeutics plc (AGY.L)March 2, 2024 | finance.yahoo.comAllergy Therapeutics PLC AGYNovember 8, 2023 | morningstar.comAllergy Therapeutics Extends Cash Runway to End of YearNovember 6, 2023 | marketwatch.comAllergy Therapeutics (LON:AGY) dips 10.0% this week as increasing losses might not be inspiring confidence among its investorsOctober 14, 2023 | finance.yahoo.comAllergy Therapeutics to Raise GBP40.75 Mln; Mandatory Cash Offer TriggeredOctober 13, 2023 | marketwatch.comRed meat allergy caused by ticks is an 'emerging public health concern': CDCJuly 31, 2023 | abcnews.go.comWhat Is A Mold Allergy? Symptoms, Causes And TreatmentsJune 22, 2023 | forbes.comAllergy Therapeutics Shares Fall on Going Concern UncertaintyJune 19, 2023 | marketwatch.comGenerational Equity Advises Allergy, Sinus & Asthma Family Health Center in its Sale to AllerVie HealthJune 14, 2023 | technews.tmcnet.comIntellia Therapeutics stock gains on CRISPR treatment resultsJune 12, 2023 | msn.comWhy Intellia Therapeutics Stock Is Rising MondayJune 12, 2023 | msn.comAllergy Therapeutics to present key scientific findings from its research portfolioJune 9, 2023 | proactiveinvestors.comGlobal Allergy Immunotherapies Market Report 2023: Growing Consumer Awareness Towards Health Benefits of Allergy Immunotherapies Fuels the SectorMay 26, 2023 | benzinga.comGlobal Food Allergy Diagnostics And Therapeutics Market Increasing Demand with Leading Player, Comprehensive Analysis, Forecast 2030May 9, 2023 | marketwatch.comPeanut Allergy Therapeutics Market Projected to Reach Significant Growth Value by 2030May 5, 2023 | marketwatch.com Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address AGY Media Mentions By Week AGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AGY News Sentiment▼0.000.60▲Average Medical News Sentiment AGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AGY Articles This Week▼10▲AGY Articles Average Week Get Allergy Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for AGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies INDV News Today APH News Today BXP News Today ANCR News Today VLG News Today EAH News Today STX News Today CEL News Today CHLL News Today HELD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:AGY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Allergy Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Allergy Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
